These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10093169)

  • 1. Does over-the-counter nicotine replacement therapy improve smokers' life expectancy?
    Lawrence WF; Smith SS; Baker TB; Fiore MC
    Tob Control; 1998; 7(4):364-8. PubMed ID: 10093169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum").
    Oster G; Delea TE; Huse DM; Regan MM; Colditz GA
    Med Care; 1996 May; 34(5):389-402. PubMed ID: 8614162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status.
    Thorndike AN; Biener L; Rigotti NA
    Am J Public Health; 2002 Mar; 92(3):437-42. PubMed ID: 11867326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-the-counter availability of nicotine replacement therapy and smoking cessation.
    Hyland A; Rezaishiraz H; Giovino G; Bauer JE; Michael Cummings K
    Nicotine Tob Res; 2005 Aug; 7(4):547-55. PubMed ID: 16085526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
    Reed MB; Anderson CM; Vaughn JW; Burns DM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2131-6. PubMed ID: 16172221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public health benefit of over-the-counter nicotine medications.
    Shiffman S; Gitchell J; Pinney JM; Burton SL; Kemper KE; Lara EA
    Tob Control; 1997; 6(4):306-10. PubMed ID: 9583628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the efficacy of over-the-counter nicotine replacement.
    Hughes JR; Shiffman S; Callas P; Zhang J
    Tob Control; 2003 Mar; 12(1):21-7. PubMed ID: 12612357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.
    Pierce JP; Gilpin EA
    JAMA; 2002 Sep; 288(10):1260-4. PubMed ID: 12215133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic rewarding of smoking cessation-facilitating drugs--a comparison of over-the-counter and prescribed nicotine replacement therapy.
    Baska T; Straka S; Basková M; Mad'ar R
    Expert Opin Pharmacother; 2004 Mar; 5(3):487-91. PubMed ID: 15013917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?
    Amodei N; Lamb RJ
    Psychol Addict Behav; 2008 Dec; 22(4):472-85. PubMed ID: 19071972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting.
    Leischow SJ; Ranger-Moore J; Muramoto ML; Matthews E
    Am J Health Behav; 2004; 28(4):291-301. PubMed ID: 15228966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?
    Shiffman S; Sweeney CT
    Health Policy; 2008 Apr; 86(1):17-26. PubMed ID: 17935827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential deaths averted in USA by replacing cigarettes with e-cigarettes.
    Levy DT; Borland R; Lindblom EN; Goniewicz ML; Meza R; Holford TR; Yuan Z; Luo Y; O'Connor RJ; Niaura R; Abrams DB
    Tob Control; 2018 Jan; 27(1):18-25. PubMed ID: 28970328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(37):867-71. PubMed ID: 9310210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the health benefits of smoking cessation in Japan.
    Avila-Tang E; Apelberg BJ; Yamaguchi N; Katanoda K; Sobue T; Samet JM
    Tob Control; 2009 Feb; 18(1):10-7. PubMed ID: 18728096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are instructions for over-the-counter nicotine replacement therapy products readable?
    Stevens AB; McDaniel KS; Glover ED; Wallace LS
    Am J Health Behav; 2007; 31 Suppl 1():S79-84. PubMed ID: 17931140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.